Search
01/01/2022
Real-world Global Outcomes of Retrograde Intrarenal Surgery in Anomalous Kidneys: A High Volume International Multicenter Study
Rojo, EG, Teoh, JYC, Castellani, D, Menendez, RB, Tanidir, Y, Galosi, AB, Bhatia, TP, Soebhali, B, Sridharan, V, Corrales, M, Vaddi, CM, Shrestha, A, Singh, A, Lakmichi, MA, Ragoori, D, Sepulveda, F, Bin Hamri, S, Ganpule, AP, Emiliani, E, Somani, B, Traxer, O, Gauhar, V. Real-world Global Outcomes of Retrograde Intrarenal Surgery in Anomalous Kidneys: A High Volume International Multicenter Study. UROLOGY. 2022; 159DOI:10.1016/j.urology.2021.10.003. PMID:34715241. IF:2.100(Q3/7D).
01/01/2022
Role and Importance of Ergonomics in Retrograde Intrarenal Surgery: Outcomes of a Narrative Review
Ong, CSH, Castellani, D, Gorelov, D, Giron-Nanne, I, Swaroop, KGJ, Corrales, M, Alshaashaa, M, Chan, VWS, Hameed, BMZ, Cho, SY, Durai, P, Gadzhiev, N, Hamri, SB, Ragoori, D, Emiliani, E, Proietti, S, Giusti, G, Somani, BK, Traxer, O, Teoh, JYC, Gauhar, V. Role and Importance of Ergonomics in Retrograde Intrarenal Surgery: Outcomes of a Narrative Review. JOURNAL OF ENDOUROLOGY. 2022; 36(1)DOI:10.1089/end.2021.0326. PMID:34210171. IF:2.700(Q2/5D).
01/01/2022
Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board
Dell'Oglio, P, Turri, F, Larcher, A, D'Hondt, F, Sanchez-Salas, R, Bochner, B, Palou, J, Weston, R, Hosseini, A, Canda, AE, Bjerggaard, J, Cacciamani, G, Olsen, KO, Gill, I, Piechaud, T, Artibani, W, van Leeuwen, PJ, Stenzl, A, Kelly, J, Dasgupta, P, Wijburg, C, Collins, JW, Desai, M, van der Poel, HG, Montorsi, F, Wiklund, P, Mottrie, A, ERUS Educ Working Grp, YAU Working Grp Robot-Assisted Sur. Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board. European Urology Focus. 2022; 8(1)DOI:10.1016/j.euf.2020.12.015. PMID:33402314. IF:5.400(Q1/2D).
01/01/2022
Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery
Mateu-Arrom, L, Gutierrez-Ruiz, C, Rubio, LS, Barea, VM, Redorta, JP, Errando-Smet, C. Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery. Actas Urologicas Espanolas. 2022; 46(1)DOI:10.1016/j.acuro.2020.11.013. PMID:34462149. IF:1.100(Q4/9D).
01/01/2022
Perioperative and Functional Outcomes of Robot-assisted Ureteroenteric Reimplantation: A Multicenter Study of Seven Referral Institutions
Carrion, A, Hussein, AA, Eun, D, Hosseini, A, Gaya, JM, Abaza, R, Bonet, X, Iqbal, U, Lee, RA, Lee, Z, Lee, M, Raventos, C, Moreno, O, Palou, J, Breda, A, Lozano, F, Vigues, F, Trilla, E, Guru, KA. Perioperative and Functional Outcomes of Robot-assisted Ureteroenteric Reimplantation: A Multicenter Study of Seven Referral Institutions. European Urology Open Science. 2022; 35DOI:10.1016/j.euros.2021.11.005. PMID:35024631. IF:2.500(Q3/6D).
01/01/2022
Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter
Kamat, AM, Lobo, N, Lerner, SP, Li, R, Matulay, JT, Palou, J, Witjes, JA, Roupret, M, Smith, AB, Chang, SS, Shore, ND, Steinberg, GD, Dinney, CP, Svatek, RS, Lamm, DL. Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter. Bladder Cancer. 2022; 8(2)DOI:10.3233/BLC-211648. PMID:. IF:1.100(Q4/9D).
01/01/2022
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models
Guerrero-Ramos, F, Subiela, JD, Rodriguez-Faba, O, Aumatell, J, Manfredi, C, Bozzini, G, Romero-Otero, J, Counago, F. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models. Bladder Cancer. 2022; 8(4)DOI:10.3233/BLC-220055. PMID:. IF:1.100(Q4/9D).
01/01/2022
A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E
Tan, WP, Bello, AP, Alvarez, CG, Guerrero-Ramos, F, Gonzalez-Padilla, DA, Nzeh, C, De la Morena, JM, De Torres, IGV, Hendricksen, K, Goizueta, FJD, Del Alamo, JF, Chiancone, F, Fedelini, P, Poggio, M, Porpiglia, F, Rodriguez, VCG, Torres, JM, Wilby, D, Robinson, R, Sousa-Escandon, A, Mata, JL, Moreno, JLP, Molina, FD, Semino, MAA, Stemberger, AT, Escudero, JC, Redorta, JP, Tan, WS. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E. Bladder Cancer. 2022; 8(4)DOI:10.3233/BLC-220026. PMID:. IF:1.100(Q4/9D).